AF
FLNA

Amalgamated Financial’s Filana Therapeutics FLNA Stock Holding History

Amalgamated Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$232K Buy
+6,239
New +$264K ﹤0.01% 1842

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Amalgamated Financial's FLNA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Filana Therapeutics (FLNA) in Q1 2022: 6,239 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #1842 among its holdings.

163 funds tracked by Wall St. Rank hold FLNA as of Q1 2022.

  • Amalgamated Financial held 6,239 shares of Filana Therapeutics worth $232K as of Q1 2022.
  • Filana Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Filana Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1842 holding.
  • 163 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.